These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 20440617

  • 1. Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of human aminopeptidase N.
    Hausheer FH, Parker AR, Petluru PN, Jair KW, Chen S, Huang Q, Chen X, Ayala PY, Shanmugarajah D, Kochat H.
    Cancer Chemother Pharmacol; 2011 Feb; 67(2):381-91. PubMed ID: 20440617
    [Abstract] [Full Text] [Related]

  • 2. Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of gamma-glutamyl transpeptidase.
    Hausheer FH, Shanmugarajah D, Leverett BD, Chen X, Huang Q, Kochat H, Petluru PN, Parker AR.
    Cancer Chemother Pharmacol; 2010 Apr; 65(5):941-51. PubMed ID: 19714332
    [Abstract] [Full Text] [Related]

  • 3. Possible (enzymatic) routes and biological sites for metabolic reduction of BNP7787, a new protector against cisplatin-induced side-effects.
    Verschraagen M, Boven E, Torun E, Hausheer FH, Bast A, van der Vijgh WJ.
    Biochem Pharmacol; 2004 Aug 01; 68(3):493-502. PubMed ID: 15242815
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetic behaviour of the chemoprotectants BNP7787 and mesna after an i.v. bolus injection in rats.
    Verschraagen M, Boven E, Torun E, Erkelens CA, Hausheer FH, van der Vijgh WJ.
    Br J Cancer; 2004 Apr 19; 90(8):1654-9. PubMed ID: 15083199
    [Abstract] [Full Text] [Related]

  • 6. Analysis of BNP7787 thiol-disulfide exchange reactions in phosphate buffer and human plasma using microscale electrochemical high performance liquid chromatography.
    Shanmugarajah D, Ding D, Huang Q, Chen X, Kochat H, Petluru PN, Ayala PY, Parker AR, Hausheer FH.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr 01; 877(10):857-66. PubMed ID: 19278906
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics and preliminary clinical data of the novel chemoprotectant BNP7787 and cisplatin and their metabolites.
    Verschraagen M, Boven E, Ruijter R, van der Born K, Berkhof J, Hausheer FH, van der Vijgh WJ.
    Clin Pharmacol Ther; 2003 Aug 01; 74(2):157-69. PubMed ID: 12891226
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Simultaneous determination of BNP7787 and its metabolite mesna in plasma and tissue by micro-HPLC with a dual electrochemical detector.
    Verschraagen M, Zwiers TH, Torun E, Donker MG, Reinhoud NJ, Van der Vijgh WJ.
    J Pharm Sci; 2003 May 01; 92(5):1040-50. PubMed ID: 12712424
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The chemical reactivity of BNP7787 and its metabolite mesna with the cytostatic agent cisplatin: comparison with the nucleophiles thiosulfate, DDTC, glutathione and its disulfide GSSG.
    Verschraagen M, Kedde MA, Hausheer FH, Van Der Vijgh WJ.
    Cancer Chemother Pharmacol; 2003 Jun 01; 51(6):499-504. PubMed ID: 12715205
    [Abstract] [Full Text] [Related]

  • 13. Modulation of platinum-induced toxicities and therapeutic index: mechanistic insights and first- and second-generation protecting agents.
    Hausheer FH, Kanter P, Cao S, Haridas K, Seetharamulu P, Reddy D, Petluru P, Zhao M, Murali D, Saxe JD, Yao S, Martinez N, Zukowski A, Rustum YM.
    Semin Oncol; 1998 Oct 01; 25(5):584-99. PubMed ID: 9783598
    [Abstract] [Full Text] [Related]

  • 14. BNP7787-mediated modulation of paclitaxel- and cisplatin-induced aberrant microtubule protein polymerization in vitro.
    Parker AR, Petluru PN, Wu M, Zhao M, Kochat H, Hausheer FH.
    Mol Cancer Ther; 2010 Sep 01; 9(9):2558-67. PubMed ID: 20807779
    [Abstract] [Full Text] [Related]

  • 15. Enzymatic and non-enzymatic mechanisms of dimesna metabolism.
    Cutler MJ, Velenosi TJ, Bodalia A, House AA, Urquhart BL, Freeman DJ.
    Amino Acids; 2015 Mar 01; 47(3):511-23. PubMed ID: 25488427
    [Abstract] [Full Text] [Related]

  • 16. Aminopeptidase N mediates the utilization of the GSH precursor CysGly by cultured neurons.
    Dringen R, Gutterer JM, Gros C, Hirrlinger J.
    J Neurosci Res; 2001 Dec 01; 66(5):1003-8. PubMed ID: 11746430
    [Abstract] [Full Text] [Related]

  • 17. Role of cysteine S-conjugate beta-lyase in the metabolism of cisplatin.
    Zhang L, Hanigan MH.
    J Pharmacol Exp Ther; 2003 Sep 01; 306(3):988-94. PubMed ID: 12750429
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of gamma-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity.
    Hanigan MH, Gallagher BC, Taylor PT, Large MK.
    Cancer Res; 1994 Nov 15; 54(22):5925-9. PubMed ID: 7954424
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
    Wainford RD, Weaver RJ, Stewart KN, Brown P, Hawksworth GM.
    Toxicology; 2008 Jul 30; 249(2-3):184-93. PubMed ID: 18583013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.